The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Exhibits Time- and Dose-Dependent Localization in Kidney, Liver, and Intestine after Intravenous Dosing: Results from High Resolution Autoradiography in Rats

被引:13
作者
Greischel, Andreas [1 ]
Binder, Rudolf [1 ]
Baierl, Juergen [1 ]
机构
[1] Boehringer Ingelheim GmbH & Co KG, D-88397 Biberach, Germany
关键词
BI; 1356; SATURABLE BINDING; IV; IMMUNOHISTOCHEMISTRY; HISTOCHEMISTRY; ORGANS; TARGET;
D O I
10.1124/dmd.110.034199
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Linagliptin is an orally active dipeptidyl peptidase-4 (DPP-4) inhibitor that is under development for the treatment of type 2 diabetes and shows dose-dependent pharmacokinetics in rats and humans. With microscopic autoradiography, the dose dependence of cellular distribution of [(3)H] linagliptin-related radioactivity was investigated in kidney at 3 h after intravenous injection of 7.4, 100, and 2000 mu g/kg [(3)H]linagliptin. Furthermore, distribution of radioactivity in kidney, liver, and small intestine was investigated in relation to time (2 min, 3 h, and 192 h) after intravenous injection of 7.4 mu g/kg [(3)H] linagliptin. The localization of radioactivity in the kidney at 3 h after administration of 7.4, 100, and 2000 mu g/kg [(3)H] linagliptin changed with increasing dose from cortical glomeruli and parts of proximal tubule parts to parts of medullar proximal tubule. In addition, the compound distribution in the kidney shifted with time after administration of 7.4 mu g/kg [(3)H] linagliptin from glomeruli (2 min) to the lower parts of proximal tubules (192 h). The radioactivity within proximal tubules was located primarily in the brush border. In the liver, the radioactivity persisted mainly around the portal triads and in the bile duct from 2 min to 192 h. In the small intestine, the radioactivity shifted from the lamina propria (2 min) to the surface of the villi and/or intestinal lumen (192 h). In conclusion, the cellular distribution pattern of [(3)H] linagliptin-related radioactivity reflected the known distribution of DPP-4. Together with the persistence of binding, this result supports the high relevance of DPP-4 binding of linagliptin for its pharmacokinetics and pharmacodynamics.
引用
收藏
页码:1443 / 1448
页数:6
相关论文
共 15 条
[1]   Linagliptin, a xanthine-based dipeptidyl peptidase-4 inhibitor with an unusual profile for the treatment of type 2 diabetes [J].
Deacon, Carolyn F. ;
Holst, Jens J. .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2010, 19 (01) :133-140
[2]   3,5-dihydro-imidazo[4,5-d]pyridazin-4-ones:: A class of potent DPP-4 inhibitors [J].
Eckhardt, Matthias ;
Hauel, Norbert ;
Himmelsbach, Frank ;
Langkopf, Elke ;
Nar, Herbert ;
Mark, Michael ;
Tadayyon, Moh ;
Thomas, Leo ;
Guth, Brian ;
Lotz, Ralf .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (11) :3158-3162
[3]   Tissue Distribution of the Novel DPP-4 Inhibitor BI 1356 is Dominated by Saturable Binding to its Target in Rats [J].
Fuchs, Holger ;
Binder, Rudolf ;
Greischel, Andreas .
BIOPHARMACEUTICS & DRUG DISPOSITION, 2009, 30 (05) :229-240
[4]   Concentration-dependent plasma protein binding of the novel dipeptidyl peptidase 4 inhibitor BI 1356 due to saturable binding to its target in plasma of mice, rats and humans [J].
Fuchs, Holger ;
Tillement, Jean-Paul ;
Urien, Saik ;
Greischel, Andreas ;
Roth, Willy .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2009, 61 (01) :55-62
[5]   IMMUNOHISTOCHEMICAL LOCALIZATION OF DIPEPTIDYL AMINOPEPTIDASE-IV IN RAT-KIDNEY, LIVER, AND SALIVARY-GLANDS [J].
FUKASAWA, KM ;
FUKASAWA, K ;
SAHARA, N ;
HARADA, M ;
KONDO, Y ;
NAGATSU, I .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1981, 29 (03) :337-343
[6]   Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine [J].
Hansen, L ;
Deacon, CF ;
Orskov, C ;
Holst, JJ .
ENDOCRINOLOGY, 1999, 140 (11) :5356-5363
[7]  
Hartel S, 1988, Adv Exp Med Biol, V240, P207
[8]   DIPEPTIDYL PEPTIDASE (DPP)-IV IN RAT ORGANS - COMPARISON OF IMMUNOHISTOCHEMISTRY AND ACTIVITY HISTOCHEMISTRY [J].
HARTEL, S ;
GOSSRAU, R ;
HANSKI, C ;
REUTTER, W .
HISTOCHEMISTRY, 1988, 89 (02) :151-161
[9]   COMPARATIVE IMMUNOHISTOCHEMISTRY AND HISTOCHEMISTRY OF DIPEPTIDYL PEPTIDASE-IV IN RAT ORGANS DURING DEVELOPMENT [J].
HARTELSCHENK, S ;
GOSSRAU, R ;
REUTTER, W .
HISTOCHEMICAL JOURNAL, 1990, 22 (10) :567-578
[10]   Pharmacokinetics, pharmacodynamics and tolerability of multiple oral doses of linagliptin, a dipeptidyl peptidase-4 inhibitor in male type 2 diabetes patients [J].
Heise, T. ;
Graefe-Mody, E. U. ;
Huettner, S. ;
Ring, A. ;
Trommeshauser, D. ;
Dugi, K. A. .
DIABETES OBESITY & METABOLISM, 2009, 11 (08) :786-794